FDA Inspection 780815 — Biomat USA, Inc
The FDA completed an inspection of Biomat USA, Inc on May 4, 2012 in Asheville, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- May 4, 2012
- Fiscal Year
- 2012
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Asheville, NC (United States)